In addition, activation of SIRT1 by small molecule compounds, natural products, Meteorin-like/Meteorin-β, or upregulation of GDF11 may be potential strategies for the treatment of ALI. This evidence concerns the gene SIRT1 and acute respiratory distress syndrome.